Trademark Overview
On Wednesday, February 26, 2025, a trademark application was filed for EZMYLES with the United States Patent and Trademark Office. The USPTO has given the EZMYLES trademark a serial number of 99057077. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, July 24, 2025. This trademark is owned by Pfizer Inc.. The EZMYLES trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
